ICU Medical, Inc.
ICUI
Market Cap$3.49B
Close$
$286.80
100.7% upside
Current Fair Value
100.7% upsideUndervalued by 100.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.49 Billion |
|---|---|
| Enterprise Value | $4.77 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-4.83 |
| Beta | 0.87 |
| Outstanding Shares | 24,492,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -29.48 |
|---|---|
| PEG | 5.3 |
| Price to Sales | 1.5 |
| Price to Book Ratio | 1.79 |
| Enterprise Value to Revenue | 2.04 |
| Enterprise Value to EBIT | 306.38 |
| Enterprise Value to Net Income | -43 |
| Total Debt to Enterprise | 0.33 |
| Debt to Equity | 0.81 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About ICU Medical, Inc.
9,000 employees
CEO: Vivek Jain ICU Medical, Inc. is a San Clemente, California-based company with global operations that develops, manufactures, and sells medical technologies used in vascular therapy, oncology, and critical care applications. ICU Medical’s products a...